lower
respiratori
tract
infect
includ
pneumonia
group
diseas
constitut
lead
worldwid
caus
pediatr
morbid
requir
hospit
mortal
childhood
pneumonia
caus
divers
longterm
sequela
restrict
obstruct
lung
diseas
well
bronchiectasi
particularli
consider
proport
children
hospit
due
communityacquir
pneumonia
cap
etiolog
cap
affect
diseas
burden
develop
longterm
sequela
mortal
mortal
sever
diseas
burden
due
cap
differ
age
therefor
predict
caus
pathogen
clinic
cours
identif
respiratori
pathogen
children
cap
need
improv
diseas
outcom
annual
season
variabl
respiratori
pathogen
caus
cap
addit
characterist
pathogen
includ
suscept
antibiot
chang
time
assess
annual
season
variabl
pathogen
characterist
could
provid
import
inform
need
establish
direct
vaccin
develop
health
care
polici
howev
comprehens
studi
topic
scarc
common
caus
pediatr
cap
highincom
countri
differ
accord
age
mycoplasma
pneumonia
mp
respiratori
virus
epidem
mp
infect
repeat
year
cycl
last
epidem
korea
macrolideresist
mp
pneumonia
rapidli
emerg
especi
asia
mp
infect
children
often
selflimit
even
patient
macrolideresist
mp
pneumonia
patient
macrolidesensit
mp
msmp
shown
defervesc
within
h
initi
macrolid
treatment
occur
approxim
patient
macrolideresist
mp
pneumonia
despit
high
preval
largescal
epidemiolog
studi
macrolideresist
mp
pneumonia
scarc
present
studi
aim
identifi
annual
season
pattern
respiratori
pathogen
pediatr
cap
requir
hospit
preval
mp
pneumonia
accord
clinic
respons
macrolid
addit
compar
clinic
characterist
accord
respiratori
pathogen
patient
pediatr
cap
conduct
retrospect
chart
review
children
hospit
cap
januari
decemb
cohort
children
younger
year
age
medic
center
south
korea
studi
period
total
children
diagnos
cap
base
clinic
featur
chest
radiographi
laboratori
find
among
children
underw
realtim
polymeras
chain
reaction
rtpcr
analys
respiratori
viru
n
mp
n
underw
serolog
test
mp
n
identifi
etiolog
cap
identifi
differ
caus
pathogen
accord
age
enrol
children
divid
four
age
group
follow
year
year
year
year
year
year
year
inform
regard
clinic
characterist
radiolog
find
laboratori
find
collect
patient
electron
medic
record
institut
review
board
particip
medic
center
review
approv
studi
protocol
pneumonia
diagnos
pediatrician
base
physic
examin
radiolog
assess
mp
pneumonia
defin
meet
least
one
follow
criteria
posit
result
rtpcr
analysi
nasopharyng
sampl
specif
igm
mp
time
hospit
due
cap
seroconvers
specif
igm
mp
fourfold
greater
increas
specif
igg
mp
acut
convalesc
stage
clinic
cours
mp
pneumonia
shown
heterogen
featur
even
patient
vitro
sensit
macrolid
result
previou
studi
shown
signific
differ
clinic
laboratori
radiolog
featur
children
macrolideresist
mp
pneumonia
msmp
pneumonia
present
studi
mp
suscept
test
macrolid
perform
instead
character
clinic
heterogen
mp
pneumonia
homogen
clinic
group
defin
clinic
msmp
macroliderefractori
mp
mrmp
macrolid
lesseffect
mp
mlep
pneumonia
accord
fever
durat
pneumonia
episod
initi
macrolid
regardless
sensit
test
macrolid
follow
fever
less
day
fever
day
day
less
day
respect
rtpcr
perform
identifi
caus
respiratori
virus
use
anyplex
ii
rv
detect
kit
seegen
seoul
korea
identifi
respiratori
virus
follow
adenoviru
adv
human
rhinoviru
hrv
influenza
viru
flu
parainfluenza
viru
piv
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
bocaviru
bov
human
coronaviru
hcov
rtpcr
perform
identifi
mp
use
abi
appli
biosystem
foster
citi
ca
usa
eudxtmpn
mlc
detect
kit
eudipia
anyplextm
ii
detect
kit
seegen
result
rtpcr
analys
serolog
titer
mp
infect
obtain
comprehens
review
laboratori
record
season
mannkendal
test
one
type
nonparametr
statist
analysi
use
detect
monoton
trend
monthli
data
annual
season
pattern
categor
variabl
number
percentag
calcul
group
analyz
use
chisquar
test
post
hoc
analys
use
examin
characterist
mp
pneumonia
group
statist
signific
chisquar
test
parametr
continu
variabl
mean
standard
deviat
sd
deriv
oneway
anova
test
conduct
compar
group
follow
bonferroni
post
hoc
test
nonparametr
continu
variabl
kruskalw
rank
test
perform
follow
dunn
post
hoc
test
statist
analys
perform
use
r
p
valu
consid
statist
signific
total
children
cap
requir
hospit
enrol
present
studi
characterist
studi
popul
present
tabl
mean
age
particip
month
sd
month
total
studi
popul
boy
number
children
hospit
due
cap
highest
fall
septemb
novemb
follow
winter
decemb
februari
spring
march
may
summer
june
august
studi
period
number
children
hospit
due
cap
highest
follow
fig
number
children
hospit
cap
due
variou
respiratori
viru
infect
highest
similar
season
annual
pattern
total
cap
among
variou
respiratori
virus
rsv
commonli
identifi
viru
especi
novemb
decemb
gradual
increas
trend
peak
fig
number
children
hospit
due
fluassoci
cap
peak
januari
march
year
largest
number
affect
patient
number
children
hospit
hmpvassoci
cap
peak
april
largest
number
affect
patient
addit
file
figur
two
epidem
mp
pneumonia
correspond
two
peak
cap
incid
mp
pneumonia
requir
hospit
children
peak
octob
novemb
year
fig
common
clinic
phenotyp
mp
pneumonia
msmp
follow
mlep
mrmp
fig
studi
period
monthli
rate
msmptotal
mp
pneumonia
mean
sd
mrmptotal
mp
pneumonia
mleptot
mp
pneumonia
fig
rate
clinic
mlep
mrmp
pneumonia
show
increas
trend
season
mannkendal
trend
test
p
p
respect
wherea
rate
clinic
msmp
pneumonia
show
signific
reduct
studi
period
season
mannkendal
trend
test
p
number
children
hospit
cap
decreas
age
tabl
children
younger
year
age
rsv
commonli
detect
respiratori
pathogen
follow
piv
hrv
children
year
age
rsv
commonli
identifi
respiratori
viru
follow
hrv
piv
children
year
age
hrv
commonli
detect
viru
follow
flu
children
older
year
age
mp
common
caus
cap
wherea
children
younger
year
age
exhibit
mp
infect
rate
clinic
mrmptotal
mp
pneumonia
highest
children
year
age
follow
adolesc
year
age
children
year
age
younger
year
age
clinic
featur
laboratori
find
accord
etiolog
children
admit
due
cap
describ
tabl
median
length
hospit
stay
due
cap
h
durat
hospit
due
cap
longest
adv
pneumonia
follow
rsv
pneumonia
system
corticosteroid
commonli
administ
mp
pneumonia
follow
rsv
pneumonia
number
children
cap
requir
oxygen
supplement
greatest
children
rsv
pneumonia
ventil
care
commonli
appli
children
adv
pneumonia
follow
rsv
pneumonia
white
blood
cell
count
highest
adv
follow
rsv
hmpv
mp
flu
blood
neutrophil
percentag
highest
mp
follow
flu
adv
hmpv
rsv
creactiv
protein
level
highest
adv
follow
mp
hmpv
flu
rsv
evalu
annual
season
pattern
respiratori
etiolog
pediatr
cap
requir
hospit
nationwid
retrospect
cohort
studi
common
caus
hospit
due
pediatr
cap
mp
rsv
peak
respect
two
epidem
mp
pneumonia
studi
period
children
hospit
cap
due
mp
pneumonia
monthli
rate
clinic
mrmp
mlep
pneumonia
show
increas
trend
togeth
compris
total
case
mp
pneumonia
studi
period
children
less
year
age
rsv
common
caus
pediatr
cap
requir
hospit
wherea
common
caus
mp
children
older
year
well
adolesc
rate
children
admit
intens
care
unit
highest
children
rsv
pneumonia
follow
adv
pneumonia
ventil
care
commonli
need
children
adv
pneumonia
follow
rsv
pneumonia
result
present
studi
provid
fundament
data
period
epidem
pathogen
caus
pediatr
cap
requir
hospit
present
studi
found
rsv
common
caus
cap
children
younger
year
age
consist
find
studi
perform
countri
regardless
detect
method
use
nation
incom
level
children
analyz
immun
respons
rsv
infect
differ
accord
age
notabl
ineffici
ineffect
immun
respons
earli
life
contribut
sever
clinic
cours
higher
incid
rsv
infect
especi
problemat
infant
frequent
affect
rsv
pneumonia
find
may
valuabl
guid
therapeut
approach
applic
immunemodulatori
drug
enhanc
immun
respons
prevent
strategi
children
cap
moreov
result
present
studi
suggest
develop
strategi
prevent
rsv
infect
especi
infant
younger
children
might
aid
decreas
worldwid
diseas
burden
due
cap
number
children
hospit
mp
pneumonia
typic
highest
octob
novemb
previou
studi
peak
incid
mp
pneumonia
show
similar
pattern
observ
present
studi
regardless
age
howev
korean
epidem
peak
rate
hospit
due
mp
pneumonia
children
occur
septemb
wherea
peak
rate
epidem
occur
novemb
addit
number
children
hospit
mp
pneumonia
epidem
smaller
epidem
find
consist
result
anoth
studi
reason
phenomenon
may
associ
exposur
mp
previou
epidem
base
vitro
macrolid
sensit
test
macrolid
resist
rate
mp
pneumonia
recent
identifi
asia
rate
differ
dramat
among
nation
defin
clinic
msmp
mlep
mrmp
accord
fever
durat
initi
macrolid
pneumonia
episod
regardless
result
vitro
macrolid
sensit
test
ratio
clinic
mlep
mrmp
total
mp
pneumonia
show
increas
trend
adjust
monthli
time
seri
howev
estim
clinic
mrmptotal
mp
pneumonia
ratio
studi
period
present
studi
far
lower
base
vitro
macrolid
sensit
test
especi
asia
therefor
result
present
studi
suggest
clinic
respons
macrolid
mp
pneumonia
real
world
might
weak
report
base
vitro
macrolid
sensit
test
could
partial
due
selflimit
featur
mp
infect
due
high
preval
mrmp
great
deal
concern
regard
secondlin
treatment
option
mrmp
includ
tetracyclin
fluoroquinolon
previou
studi
report
signific
differ
respect
clinic
radiolog
find
mrmp
msmp
pneumonia
children
combin
result
present
previou
studi
consider
proport
case
macrolideresist
mp
pneumonia
might
recategor
clinic
msmp
mlep
pneumonia
therefor
firstlin
treatment
mp
pneumonia
initi
start
even
case
mrmp
pneumonia
consid
exagger
immun
respons
children
mp
pneumonia
applic
immunemodul
corticosteroid
immunoglobulin
rather
antibiot
might
play
import
role
manag
mp
pneumonia
even
case
mlep
mrmp
pneumonia
select
proper
treatment
strategi
mlep
mrmp
pneumonia
consider
divers
clinic
cours
includ
selflimit
featur
combin
immun
respons
case
might
import
result
vitro
sensit
test
macrolid
studi
limit
first
might
select
bia
due
includ
case
cap
korean
children
second
patient
might
misclassifi
mp
pneumonia
respiratori
viru
detect
group
due
sampl
error
includ
inappropri
sputum
specimen
lack
repetit
followup
mpspecif
igm
patient
initi
neg
result
mpspecif
igm
due
retrospect
studi
design
techniqu
rtpcr
detect
respiratori
virus
mp
serolog
mp
perform
particip
present
studi
includ
cap
caus
typic
bacteri
pathogen
therefor
could
identifi
timedepend
chang
occurr
cap
caus
typic
bacteri
pathogen
alon
caus
coinfect
typic
bacteria
virus
howev
follow
introduct
pneumococc
conjug
vaccin
haemophilu
influenza
type
b
vaccin
diseas
burden
due
bacteri
pneumonia
significantli
decreas
therefor
clinic
defin
msmp
mrmp
mlep
pneumonia
group
sole
base
fever
durat
initi
administr
macrolid
regardless
result
vitro
test
macrolid
sensit
result
vitro
sensit
test
antibiot
alway
correspond
vivo
sensit
test
antibiot
administr
immunemodul
might
play
import
role
treatment
mp
pneumonia
case
applic
clinic
classif
mp
pneumonia
rather
result
vitro
macrolid
sensit
test
might
help
manag
mp
pneumonia
especi
signific
case
mlep
mrmp
pneumonia
era
high
rate
antibioticrefractori
mp
identifi
annual
season
pattern
caus
pathogen
children
cap
requir
hospit
throughout
studi
period
mp
rsv
common
caus
cap
cyclic
peak
specif
season
diseas
burden
due
pediatr
cap
requir
hospit
larg
due
rsv
pneumonia
especi
infant
young
children
rel
lower
rate
clinic
mlep
mrmp
pneumonia
contrari
known
high
preval
macroliderefractori
mp
pneumonia
highlight
appropri
treatment
strategi
patient
mp
pneumonia
result
present
studi
may
aid
establish
treatment
manag
strategi
pediatr
cap
polici
reduc
diseas
burden
improv
public
health
polici
children
cap
